Condition
Bisphosphonate-Associated Osteonecrosis of the Jaw
Total Trials
5
Recruiting
1
Active
2
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (2)
Trial Status
Unknown1
Active Not Recruiting1
Not Yet Recruiting1
Recruiting1
Completed1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT06622421Not ApplicableNot Yet RecruitingPrimary
Piezoeletric Surgery vs Conventional Surgery for Treatment of MRONJ
NCT06457776Recruiting
Medication Related Osteonecrosis of the Jaws (MRONJ) in a Cohort of Patients Treated by Antiresorptive Drugs
NCT02932501Active Not Recruiting
Medication-related Osteonecrosis of the Jaw (MRONJ) Registry
NCT01325142Completed
Genetic Risk of Osteonecrosis of the Jaw (ONJ) in Patients With Metastatic Cancer
NCT02198001Not ApplicableUnknownPrimary
Prospective Randomized Study: Assessment of PRF Efficacy in Prevention of Jaw Osteonecrosis After Tooth Extraction
Showing all 5 trials